Clostridioides difficile clinical diagnostic test methods and results are associated with recovery of C. difficile by stool culture.|https://dx.doi.org/10.1128/spectrum.03408-25
Improvement in post-hemispherotomy cerebral salt-wasting syndrome following intubation: A case report.|https://dx.doi.org/10.1297/cpe.2025-0050
Combined medial patellofemoral ligament and medial quadriceps tendon-femoral ligament reconstruction for patellar instability: a systematic review.|https://dx.doi.org/10.1186/s13018-025-06621-2
Fecal Microbiota Transplantation in 2025: Two Steps Forward, One Step Back.|https://dx.doi.org/10.1007/s11894-025-01030-1
A retrospective Follow-Up after derotational distal femoral osteotomy combined with medial patellofemoral ligament reconstruction for the treatment of recurrent patellar dislocation.|https://dx.doi.org/10.1186/s13018-025-06646-7
Safety and efficacy of oral microbiome therapy for the treatment of recurrent Clostridioides difficile infection: a systematic review and meta-analysis of randomized controlled trials.|https://dx.doi.org/10.1080/00365521.2026.2616310
Phase variable colony morphotypes of Clostridioides difficile elicit distinct host responses during acute infection.|https://dx.doi.org/10.64898/2026.01.09.698580
Machine Learning Model Predicts Recurrent Clostridioides difficile Infection in Patients With Inflammatory Bowel Disease (Recur CDI-IBD).|https://dx.doi.org/10.14309/ajg.0000000000003922
Distinct T and innate-like lymphocyte reprogramming following lyophilized fecal microbiota transplantation in recurrent C. difficile infection.|https://dx.doi.org/10.1080/19490976.2026.2620127
Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study.|https://dx.doi.org/10.1016/S1473-3099(25)00721-2
Assessment of Rifaximin and Rifampicin Resistance Across Clostridioides Difficile Ribotypes: A Systematic Review and Meta-Analysis.|https://dx.doi.org/10.1093/lambio/ovag018
Microbiota-Driven Strategies for Managing IBD-Associated Risks: From Infections to Mental Health.|https://dx.doi.org/10.3390/ph19010118
Fecal Microbiota Transplantation Donor Screening: Is Dientamoeba fragilis a Valid Criterion for Donor Exclusion? A Longitudinal Study of a Swiss Cohort.|https://dx.doi.org/10.3390/microorganisms14010217
"Hiding in Plain Sight": A Retrospective Clinical and Microbiological Review of Vancomycin-Dependent Enterococci at a Tertiary Care Centre-A Case Report.|https://dx.doi.org/10.3390/microorganisms14010193
Burden of Clostridioides difficile Infection and Risk Factors for Recurrences in an Italian Tertiary Care University Hospital: A Prospective Observational Study.|https://dx.doi.org/10.3390/antibiotics15010023
Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2024.|https://dx.doi.org/10.33321/cdi.2026.50.007
Outcomes of Medial Patellofemoral Ligament Reconstruction With Concomitant Tibial Tubercle Osteotomy for Failed Surgery for Patellar Instability Versus Primary Medial Patellofemoral Ligament Reconstruction With Concomitant Tibial Tubercle Osteotomy.|https://dx.doi.org/10.1177/03635465251409151
Long-Term Follow-Up After Fecal Microbiota Transplantation via Freeze-Dried Capsules for Recurrent Clostridioides difficile Infection.|https://dx.doi.org/10.20411/pai.v11i1.868
Recurrent severe viral infection in a child with inherited complete TBK1 deficiency.|https://dx.doi.org/10.70962/jhi.20250058
Science of fecal microbiota transplant: From history to cutting-edge clinical practice.|https://dx.doi.org/10.4253/wjge.v18.i1.113133
Bezlotoxumab for prevention of Clostridioides difficile recurrence in patients with inflammatory bowel disease: a retrospective multicenter experience.|https://dx.doi.org/10.20524/aog.2026.1029
Clinical and Pharmacoeconomic evaluation of Fidaxomicin in patients over 65 years of age and immunocompromised patients with recurrent and refractory Clostridioides difficile infection.|https://dx.doi.org/10.1186/s12879-026-12611-4
Fecal microbiota transplantation in compassionate indications: French experience from 2019 to 2022.|https://dx.doi.org/10.1016/j.idnow.2026.105247
Clostridioides difficile colonization of Twin Patients Recovering From Infant Botulism.|https://dx.doi.org/10.1016/j.anaerobe.2026.103022
Persistent fever: Anti-KS syndrome overlaps with multidrug-resistant infections (MDRO) in a cervical spinal cord injury (CSCI) patient.|https://dx.doi.org/10.1016/j.rmcr.2026.102369
Modulation of Clostridioides difficile virulence by metabolites derived from probiotic consortia and genetically edited strains.|https://dx.doi.org/10.1016/j.biotechadv.2026.108818
Analysis of gut microbiota in super donors for fecal microbiota transplantation and isolated gut commensal bacteria of inhibition against Clostridioides difficile.|https://dx.doi.org/10.5217/ir.2025.00179
Evaluation of the antibacterial activity of the natural product Î±-mangostin against Clostridioides difficile.|https://dx.doi.org/10.1371/journal.pone.0341857
Clostridioides difficile infection in pediatric inflammatory bowel disease: current understanding and clinical challenges.|https://dx.doi.org/10.3389/fped.2025.1753289
